Quote:-
niet Short selling of glove shares today
topglov 4,971,100 shares worth 17.065 million MYR average price 3.4328 total volume 37846900
supermx 3,054,400 shares worth 8.674 million MYR average price 2.8398 total vol. 20346900
kossan 593,500 shares worth 1.7010 million MYR average price 2.8866 total vol 8444500
harta 107100 shares worth 0.705942 million MYR average price 6.5914 total vol 11051700

percent shorted
top glov 13%
supermx 15%
kossan 7%
harta 0.9%
09/09/2021 11:07 PM
=====
Hopefully KILL the shorties kaw kaw

@Pgraduate123 Nepo, I had bought harta at 3.84 before.
Few years ago..
09/09/2021 7:25 PM
=======
@pgraduate,
You smart.
I shall buy in my 2nd batch once RM 6 level loses

Harta can get raw material cheap because Nitrile gloves are produced from synthetic rubber (oil) They are flexible and stretchable. These attributes are used in medical and chemical fields equally.
Because our country is a oil production country..

Correct me is I m wrong

arta is one of the top-notch glove co in the world. slowly buy in at present level. Don't miss this chance.

Btw, RM 5 seems rather 'impossible' because of the additional capacity of production

yes, RM 5 can buy 1st batch

make sense also...but hopefully not bottom fishing at the mid of the hill...t

Quite scary..it looks like no support at all..

Now Icap becomes famous because of SAM.
It is an
undervalued gem now.

It looks like insiders and operators are not in the same side...

Quite interesting.

Mr Soh Tong Hwa,

on 1 Sept 2021 sold 40 lots of warrant @ RM 0.38.
On 2 Sept 2021, bought back warrants 40 lots @ RM 0.385

Good to see @shareinvestor promotes kaw kae Hoping more people buy iin..this gem

Now is the time for Padini to make a comeback.
Those who haven't collected, sure regret. Already gave you plenty of time to buy during pandemic..

（吉隆坡3日讯）Apex保健（AHEALTH，7090，主板消费股）在新加坡的独资子公司 ——Apex Pharma Marketing（APM）获得国药（Sinopharm）疫苗供应合约。

Apex保健周五发文告指出，APM已在8月31日，和Innova生物医学公司签署供应协议，供应国药疫苗予新加坡私人诊所和医院。

该公司补充，第一批疫苗供应量为3万1600剂，会在9月中到货。

周五闭市，Apex保健收报3.01令吉，无起落，有1万8200股易手。

3 Sept 2021

Apex Healthcare Bhd said it has inked an agreement with Innova Bio-Medical Pte Ltd to supply the Sinopharm Covid-19 vaccine to private healthcare practitioners in Singapore. Innova is part of the Innova Medical Group, a global company specializing in innovative screening, testing and diagnostics for cancer, heart disease, arterial calcification, stroke, and virus detection focused on infectious diseases. Under the deal, Innova will supply the Chinese-made vaccine to Apex’s wholly-owned unit in Singapore, Apex Pharma Marketing Pte Ltd, for onward sale and distribution to hospitals and private clinics within the city state, said Apex Healthcare.

Oversupply

Quite funny..

It looks like you want to buy at the lower price.. so you hope the price tumbles...is it?

Haha， when share price dropped, positive comments keep silent while negative comments begin spreading like Covid-19 virus pandemic..this is called share price movements speak louder than word.

https://www.businessinsider.com/warren-buffett-afghanistan-ovarian-lottery-luck-inequality-higher-taxes-rich-2021-8?amp

Inequality starts at birth
==================
Warren Buffett's talent for spotting undervalued businesses has made him one of the wealthiest men in history. However, he has repeatedly underscored the outsized role that luck has played in his career, and highlighted Afghanistan to hammer his point home.

Winning the lottery
The famed investor and Berkshire Hathaway CEO popularized the term "ovarian lottery," or the idea that the circumstances of a person's birth shape their opportunities in life.

"It's the most important event in which you'll ever participate," Buffett said at Berkshire's annual shareholder meeting in 1997. "It's going to determine way more than what school you go to, how hard you work, all kinds of things. You're going to get one ball drawn out of a barrel that probably contains 5.7 billion balls now, and that's you."

Buffett noted that he and his business partner, Charlie Munger, won the lottery by being born white, smart, able-bodied, male, and in America.


"When we were born, the odds were over 30-to-1 against being born in the United States," Buffett said at the meeting. "Just winning that portion of the lottery, enormous plus. We wouldn't be worth a damn in Afghanistan."

"We'd be giving talks, nobody'd be listening," he continued. "Terrible."

The US has richly rewarded the two men's knack for valuing businesses, but that wouldn't be the case in every country, Buffett continued.

"Is that the greatest talent in the world? No," he said. "It just happens to be something that pays off like crazy in this system."


Buffett repeated that point more than a decade later, adding that many important jobs are far less lucrative.

"The market system rewards me outlandishly for what I do," Buffett told Time magazine in 2012. "But that doesn't mean I'm any more deserving of a good life than a teacher or a doctor or someone who fights in Afghanistan."

Sharing the jackpot
Buffett has drawn comparisons between the US and Afghanistan to emphasize how inequality starts at birth. He's called for a system that incentivizes people to use their skills if they're valued by the market and society, but also helps people who don't hit the jackpot in life.

That type of system "makes sure that just because at that one moment in time they got the wrong ticket, they don't live a life that's dramatically worse than the people that were luckier," Buffett said at the 1997 meeting.


The Berkshire chief has also pointed to Afghanistan to make his case for higher taxes on the wealthy.

"While the poor and middle class fight for us in Afghanistan, and while most Americans struggle to make ends meet, we mega-rich continue to get our extraordinary tax breaks," he said in a New York Times column titled "Stop Coddling the Super-Rich" in 2011.

Buffett's comments show he's aware of his numerous advantages and privileges, which include living in a country that rewards his skills and protects his wealth. Afghanistan is his go-to example of a much tougher situation, fueling his belief that the less fortunate should be lifted up and the most affluent should share more of their wealth.

What happened? share price tumble.
Any bad news?

Sinchew 22 April 2021

和乐精密（HPMT,5291,主板工业产品服务组）在2021财政年至今切割工具的订单强劲，带来强劲的转机，分析员预期在需求稳健复苏下，公司产能使用率将升高。

丰隆研究在会晤和乐精密后指出，据管理层表示，今年的订单进度大致反映2018-2019财政年的趋势。

据了解，随着今年订单增长加快，首季产能利用率达到约65%，优于第四季的60%和2020财政年的50至60%。

增长的主要动力来自分销商对经济复苏感到乐观而展开的补货活动，原因是去年的库存水平较低。管理层维持2021财政年65至75%的利用率的指引导。

有意购新设备
受今年复苏的提振，该公司正探讨在2022年将现有56台设备中再增加2台CNC机床。不过，此计划很大程度上取决于年杪的需求而定。购置此类机器，将可获得资本补贴，而降低税率。自冠病爆发以来，该公司推迟机械采购计划，最近一次采购是在2018年。

原材料涨价
成本压力方面，据了解，该公司主要原材料碳化钨在2021年首季至今已增长约15%。尽管如此，相信该公司通常会保存大约3个月的材料存货，这将能够转嫁成本，从而减轻对赚幅的冲击。

今年切割工具市场更稳健，将有助该公司更有效地转移成本。

同时，2021年至今为止，欧元区、中国、日本和台湾等主要市场的制造业采购经理指数（PMI）都录得上涨数据。欧元区（即德国和意大利）也显示该指数按月连续扩张。这对该公司来说是个好兆头，因为这两国是冠病爆发前该公司的主要贡献来源。同时，亚洲市场的数据也保持扩张。尽管德国可能因为冠病而出现新的停工，但管理层并未感觉到分销商的订单或情绪明显下降。

该行在更新资产负债表项目，合并明年2台机器的额外产能后，将2021至2022财政年的盈利预测调高2.4至6.4%，以及新预测2023财政年的盈利为1510万令吉。保持“守住”评级，同时将本益比估值从12倍提高至15倍，因此目标价从49仙上调至62仙。

The good thing about buying cash rich co is the company will support the share price for you.
Same thing go to your family. If you have cash rich parents， they will support your living. You live in worry-free conditions..

发布 “预算前声明” 财长：供相关者提供反馈
https://www.chinapress.com.my/?p=2654279

30 Aug 21, lowest was RM 1.94
Share buy back price was RM 1.94
I suspect it more like supporting the price to a certain level so that ex bonus price able to maintain at the level above RM1 ..

Lower profit Most likely due to production cost increase, for instant, sugar, palm oil

https://www.asgam.com/index.php/2021/08/29/genting-reveals-us650000-daily-ebitda-at-resorts-world-las-vegas-during-first-week-of-operation/

I loaded@ RM 10.48

No answer.
One group said overvalued because still incurred loss. But EPF continue bought in despite the co incurred loss..

Ofi profit tumble.
But what is curious is the management didn't expl6 much why profit tumble. They just simply mentioned it is due to Covid-19 lockdown..

Omg miss the boat

Tan Teng Boo

Date:19.08.2021

15,000 (Number of Ordinary Shares Acquired)

RM1.9847 (Transaction Price Per Share (RM))

25,000 (Number of Ordinary Shares after acquisition)


Tan Teng Boo

Acquisition of Shares through Open Market

Ofi also good, robust growth but Ofi performance not stable, more suitable for young investors.

I, old man prefer stable stock with good dividend like Cocoaland

Indeed happy to hear the bonus news.

Hopefully can buy back below RM14..because my buying price is at high end..
I predict tomorrow still facing profit-taking..

@Powerplay666, afraid later on heart attack..

I exit first..very bad weather..

After curi ayam just noe, I believe the worst has over.
Now I can sit back and relax as before and enjoy some coffee.

top up some RM14

buy in come on

Current year prospects
The on-going COVID-19 pandemic continues to impact the commercial aerospace industry. According
to Industry group IATA, global air passenger traffic has recovered to 40% of pre-pandemic levels in June
2021, with domestic air traffic recovering to close to 80% of pre-pandemic levels. Global passenger traffic
is expected to return to pre–COVID-19 levels by 2024.
The growth momentum in Cloud Computing, 5G Telecommunications, Artificial intelligence (AI) and
Digitization continues to fuel strong demand for semiconductor chips and storage devices. According to
SEMI, some 29 Fabs will be constructed in 2021 and 2022, triggering strong demand for semiconductor
equipment. Global shortages of semiconductor chips which is expected to last until end of 2023 should
drive the demand for semiconductor equipment. We are investing in new machines and space to meet
increasing demand for our products. This also includes an expansion of our manufacturing operations in
Thailand by securing the factory which is scheduled to start mass production by December 2021. In
addition, we continue to explore projects with our existing and new customers.

=============
Prospect still very good. Don't worry to much..

During the period under review, the Group withdrew RM54.4 million from its’ investment in unit trust
compared to the increase of RM11.1 million a year before, resulting in financing activities generating
net cash of RM30.7 million to the Group. Meanwhile, as reported in the last quarter’s report, the Group
successfully established a joint venture (“Joint Venture”) with Hyundai Transys Inc. for the
establishment of PT APM Hyundai Transys Indonesia to manufacture and supply automobile seats and
their related parts and components to its counterpart in Indonesia, namely PT Hyundai Motor
Manufacturing Indonesia. The amount of RM16.3 million, being the final tranche of capital for the Joint
Venture on the Group’ portion was disbursed in Q1’2021.

COMMENTARY ON PROSPECTS AND TARGETS, STRATEGIES AND RISKS
APM Group is principally involved in the design, manufacturing, assembly and production of automotive
and mobility components. Whilst APM Group’s main operations are located in Malaysia, the Group is also
present in various other jurisdictions, including United States of America, Netherlands, Australia, Thailand,
Vietnam, the Republic of Indonesia and recently, the United Kingdom.
Notwithstanding the Malaysian Automotive Association’s (MAA) downward revision of its Total Industry
Volume forecast for 2021 by about 5% (as announced by the MAA on 21 January 2021), the Group is
positive that its prospects will improve going into Q3’21 and Q4’21 in view of inoculations efforts against
the COVID-19 pandemic in Malaysia and elsewhere being ramped up recently; the implementation of
economic stimuli plans, such as the PEMERKASA Plus by the government to further mitigate the impact
of this pandemic; Bank Negara’s decision to maintain the benchmark Overnight Policy Rate (OPR) at 1.75%,
which will provide additional policy stimulus to accelerate the pace of economic recovery; the potential
introduction of newer vehicle models by carmakers at competitive prices to sustain buying interest; and
more importantly, the anticipated resumption of operations (whether fully or partially) for those in the
automotive industry whose employees have been fully vaccinated by Q3’21. There are no plans for lay-offs
or plant closures going forward.
However, we expect such improvements to be gradual in view of the uncertainties stemming from the
escalation of major raw material prices, such as Polyurethane or PU padding chemical, plastic resins and
steel as well as the rise of logistical cost, all of which are expected to dampen the recovery progress.
By and large, the Group remains cautious in its approach as overall consumer sentiments are anticipated to
remain weak for now due to apprehension and uncertainties in the economic environment. Consequently,
the Group does not anticipate full pre-pandemic recovery to occur in the near or mid-term.
The Group will nonetheless maintain its focus on long terms strategies for business sustainability and
continue to strive for success expeditiously through mergers, acquisitions, strategic partnerships, joint
ventures and alliances

Be patience, one day it will be silver lining

Quote

Posted by icedvestor > Aug 25, 2021 7:45 PM | Report Abuse

this explains the share buy back.. haha...huat ah...

≠==≠=======≠{{{}}}}====≠=
You spot on @icedvestor,
Most probably share buy back is due to ten cents dividend.

Good morning ladies and gentlemen.

Today you need to close your eyes and Hold tight with your arm,most probably today quite volatile and challenging.

Hopefully no heart attack..

I believe this is a very good stock.

True indeed. Price always run ahead of current QR. I will add on if dip down..

Omg, bad result..

If today can close at RM 1.35, then outlook is good..

Buy in during bad time
Relax in good time
That is the logic of the stock market.
Hari ini saya boleh goyang kaki.. peaceful mind.

Keep it up, Icap